Overview Late Phase II Study of TS-142 in Patients With Insomnia Status: Recruiting Trial end date: 2021-12-31 Target enrollment: Participant gender: Summary This is a randomized, double-blind, multi-center, placebo-controlled, parallel-group exploratory study in patients with insomnia. Phase: Phase 2 Details Lead Sponsor: Taisho Pharmaceutical Co., Ltd.